Ligand Pharmaceuticals (LGND) Tax Rate (2010 - 2026)

Ligand Pharmaceuticals has disclosed Tax Rate across 17 years of filings, most recently posting 44.99% for Q1 2026.

• Tax Rate for Q1 2026 came in at 44.99%, up 2959.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.94% (down 74.0% YoY), and the FY2025 annual result was 21.71%, down 23842.0% from the prior year.
• Tax Rate came in at 44.99% for Q1 2026 at Ligand Pharmaceuticals, up from 21.13% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 160.21% in Q4 2022 to a low of 45.47% in Q2 2022.
• The 5-year median for Tax Rate is 20.69% (2024), against an average of 21.24%.
• Across the five-year window, Tax Rate soared 17273 bps in 2022 and sank 16659 bps in 2023, its largest moves.
• Ligand Pharmaceuticals' Tax Rate stood at 160.21% in 2022, then plunged by 104 bps to 6.38% in 2023, then jumped by 424 bps to 20.69% in 2024, then rose by 2 bps to 21.13% in 2025, then jumped by 113 bps to 44.99% in 2026.
• The last three Tax Rate figures came in at 44.99% (Q1 2026), 21.13% (Q4 2025), and 16.91% (Q3 2025), per Business Quant data.